P1b, N=20, Not yet recruiting, Aivita Biomedical, Inc. | Trial completion date: Jan 2023 --> Oct 2023 | Trial primary completion date: Jun 2020 --> Oct 2021
4 years ago
Clinical • Trial completion date • Trial primary completion date • Checkpoint inhibition
|
PD-L1 (Programmed death ligand 1) • BRAF (B-raf proto-oncogene)